Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam · Delayed Price · Currency is VND 61,200
+100 (0.16%)
At close: Jul 24, 2026
HNX:DP3 Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 23, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,315,796 | 1,135,196 | 1,253,446 | 1,408,246 | 808,400 | 971,800 | |
Market Cap Growth | 15.69% | -9.43% | -10.99% | 74.20% | -16.81% | 30.18% |
Enterprise Value | 890,176 | 736,739 | 929,277 | 1,160,824 | 640,122 | 859,776 |
Last Close Price | 61200.00 | 49452.93 | 51962.14 | 55963.72 | 29640.19 | 33788.29 |
PE Ratio | 7.56 | 7.27 | 10.34 | 11.24 | 7.43 | 10.31 |
Forward PE | - | 7.61 | - | - | - | - |
PS Ratio | 2.55 | 2.59 | 3.00 | 3.44 | 1.67 | 2.55 |
PB Ratio | 2.20 | 1.86 | 2.42 | 3.01 | 1.94 | 2.65 |
P/TBV Ratio | 3.91 | 1.92 | 2.51 | 3.14 | 1.97 | 2.70 |
P/FCF Ratio | 14.01 | 7.89 | 13.86 | 9.60 | 9.61 | 37.58 |
P/OCF Ratio | 12.96 | 7.49 | 13.64 | 9.20 | 8.15 | 36.94 |
EV/Sales Ratio | 1.73 | 1.68 | 2.23 | 2.83 | 1.32 | 2.26 |
EV/EBITDA Ratio | 4.53 | 4.03 | 6.21 | 7.69 | - | - |
EV/EBIT Ratio | 4.83 | 4.33 | 6.80 | 8.48 | 5.01 | 7.67 |
EV/FCF Ratio | 9.48 | 5.12 | 10.27 | 7.91 | 7.61 | 33.24 |
Debt / Equity Ratio | 0.04 | 0.06 | - | 0.02 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.11 | 0.19 | - | 0.05 | - | - |
Debt / FCF Ratio | 0.23 | 0.24 | - | 0.05 | 0.06 | 0.14 |
Net Debt / Equity Ratio | -0.71 | -0.72 | -0.66 | -0.64 | -0.48 | -0.43 |
Net Debt / EBITDA Ratio | -2.16 | -2.41 | -2.28 | -1.98 | - | - |
Net Debt / FCF Ratio | -4.53 | -3.07 | -3.78 | -2.03 | -2.39 | -6.12 |
Asset Turnover | 0.71 | 0.64 | 0.71 | 0.76 | 1.02 | 0.86 |
Inventory Turnover | 2.62 | 2.99 | 2.94 | 2.10 | 2.17 | 1.90 |
Quick Ratio | 3.05 | 3.61 | 4.29 | 3.25 | 2.60 | 2.31 |
Current Ratio | 3.56 | 4.03 | 4.88 | 3.79 | 3.43 | 3.22 |
Return on Equity (ROE) | 31.38% | 27.64% | 24.55% | 28.28% | 27.77% | 26.46% |
Return on Assets (ROA) | 15.91% | 15.60% | 14.50% | 15.87% | 16.76% | 15.81% |
Return on Invested Capital (ROIC) | 84.74% | 79.64% | 62.83% | 56.58% | 48.04% | 44.85% |
Return on Capital Employed (ROCE) | 30.80% | 27.90% | 26.30% | 29.20% | 30.60% | 30.60% |
Earnings Yield | 13.22% | 13.75% | 9.67% | 8.89% | 13.46% | 9.70% |
FCF Yield | 7.14% | 12.68% | 7.22% | 10.42% | 10.41% | 2.66% |
Dividend Yield | 6.55% | 8.09% | 5.77% | 5.36% | - | 7.10% |
Payout Ratio | 37.04% | 41.29% | 53.22% | 54.84% | 45.84% | 70.55% |
Buyback Yield / Dilution | -0.01% | - | - | 5.00% | -5.27% | 0.00% |
Total Shareholder Return | 6.54% | 8.09% | 5.77% | 10.36% | -5.27% | 7.11% |